Identification and Clinical Correlation Analysis of IFI44 in Systemic Lupus Erythematosus Combined with Bioinformatics and Immune Infiltration Analysis

References

• Teruel M, Alarcón-Riquelme ME. The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun. 2016;74:161–175. doi:10.1016/j.jaut.2016.08.001
   PubMed Web of Science ®Google Scholar
• Ameer MA, Chaudhry H, Mushtaq J, et al. An overview of Systemic Lupus Erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022;14(10):e30330. doi:10.7759/cureus.30330
   PubMed Web of Science ®Google Scholar
• Infante B, Mercuri S, Dello Strologo A, et al. Unraveling the link between interferon-α and systemic lupus erythematosus: from the molecular mechanisms to target therapies. Int J Mol Sci. 2022;23(24). doi:10.3390/ijms232415998
   Web of Science ®Google Scholar
• Salvi V, Gianello V, Busatto S, et al. Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7. JCI Insight. 2018;3(10). doi:10.1172/jci.insight.98204
   PubMed Web of Science ®Google Scholar
• Demers-Mathieu V. Optimal selection of IFN-α-inducible genes to determine type I interferon signature improves the diagnosis of systemic lupus erythematosus. Biomedicines. 2023;11(3):864. doi:10.3390/biomedicines11030864
   PubMed Web of Science ®Google Scholar
• Siddiqi KZ, Wilhelm TR, Ulff-Møller CJ, Jacobsen S. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies. Transl Res. 2021;238:63–75. doi:10.1016/j.trsl.2021.07.006
   PubMed Web of Science ®Google Scholar
• Yuan Y, Ma H, Ye Z, Jing W, Jiang Z. Interferon-stimulated gene 15 expression in systemic lupus erythematosus: diagnostic value and association with lymphocytopenia. Z Rheumatol. 2018;77(3):256–262. doi:10.1007/s00393-017-0274-8
   PubMed Web of Science ®Google Scholar
• Huang X, Shen N, Bao C, Gu Y, Wu L, Chen S. Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells. Arthritis Res Ther. 2008;10(4):R91. doi:10.1186/ar2475
   PubMed Web of Science ®Google Scholar
• Shen M, Duan C, Xie C, et al. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus. Front Immunol. 2022;13:962393. doi:10.3389/fimmu.2022.962393
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu R, Tan Y, Huang J, Luo S. Novel polymorphism of IFI44L associated with the susceptibility and clinical characteristics of systemic lupus erythematosus in a Chinese population. Int Immunopharmacol. 2023;117:109979. doi:10.1016/j.intimp.2023.109979
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Tummala R. Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials. Mod Rheumatol. 2021;31(1):1–12. doi:10.1080/14397595.2020.1812201
   PubMed Web of Science ®Google Scholar
• Zhang B, Liu L, Zhou T, et al. A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus. Clin Immunol. 2020;221:108612. doi:10.1016/j.clim.2020.108612
   PubMed Web of Science ®Google Scholar
• Jiang Z, Shao M, Dai X, Pan Z, Liu D. Identification of diagnostic biomarkers in systemic lupus erythematosus based on bioinformatics analysis and machine learning. Front Genet. 2022;13:865559. doi:10.3389/fgene.2022.865559
   PubMed Web of Science ®Google Scholar
• González-Navajas JM, Lee J, David M, Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol. 2012;12(2):125–135. doi:10.1038/nri3133
   PubMed Web of Science ®Google Scholar
• Vazquez MI, Catalan-Dibene J, Zlotnik A. B cells responses and cytokine production are regulated by their immune microenvironment. Cytokine. 2015;74(2):318–326. doi:10.1016/j.cyto.2015.02.007
   PubMed Web of Science ®Google Scholar
• Thacker SG, Zhao W, Smith CK, et al. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis. Arthritis Rheum. 2012;64(9):2975–2985. doi:10.1002/art.34504
   PubMedGoogle Scholar
• Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB. Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol. 2020;67:87–94. doi:10.1016/j.coi.2020.10.014
   PubMed Web of Science ®Google Scholar
• Pan H, Wang X, Huang W, et al. Interferon-induced protein 44 correlated with immune infiltration serves as a potential prognostic indicator in head and neck squamous cell carcinoma. Front Oncol. 2020;10:557157. doi:10.3389/fonc.2020.557157
   PubMed Web of Science ®Google Scholar
• Shen L, Lan L, Zhu T, et al. Identification and validation of IFI44 as key biomarker in lupus nephritis. Front Med. 2021;8:762848. doi:10.3389/fmed.2021.762848
   Web of Science ®Google Scholar
• Wang Y, Jia W, Ma Q, et al. Identification of IFI44L as a new candidate molecular marker for systemic lupus erythematosus. Clin Exp Rheumatol. 2023;41(1):48–59. doi:10.55563/clinexprheumatol/q3aa6s
   PubMed Web of Science ®Google Scholar
• Busse DC, Habgood-Coote D, Clare S, et al. Interferon-induced protein 44 and interferon-induced protein 44-like restrict replication of respiratory syncytial virus. J Virol. 2020;94(18). doi:10.1128/JVI.00297-20
   PubMed Web of Science ®Google Scholar
• Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005;52(5):1491–1503. doi:10.1002/art.21031
   PubMed Web of Science ®Google Scholar
• Espinosa M, Arenas MD, Aumente MD, et al. Anemia associated with pegylated interferon-alpha2a and alpha2b therapy in hemodialysis patients. Clin Nephrol. 2007;67(6):366–373. doi:10.5414/cnp67366
   PubMed Web of Science ®Google Scholar
• Northcott M, Jones S, Koelmeyer R, et al. Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis. Lupus Sci Med. 2022;9(1):e000625. doi:10.1136/lupus-2021-000625
   PubMed Web of Science ®Google Scholar
• Choi MY, Fritzler MJ. Autoantibodies in SLE: prediction and the p value matrix. Lupus. 2019;28(11):1285–1293. doi:10.1177/0961203319868531
   PubMed Web of Science ®Google Scholar
• Coss SL, Zhou D, Chua GT, et al. The complement system and human autoimmune diseases. J Autoimmun. 2022:102979. doi:10.1016/j.jaut.2022.102979
   PubMedGoogle Scholar
• Tanaka Y, Kusuda M, Yamaguchi Y. Interferons and systemic lupus erythematosus: pathogenesis, clinical features and treatments in interferon-driven disease. Mod Rheumatol. 2022. doi:10.1093/mr/roac140
   Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686. doi:10.1002/art.34473
   PubMed Web of Science ®Google Scholar
• Ding L, Chen X, Cheng H, Zhang T, Li Z. Advances in IgA glycosylation and its correlation with diseases. Front Chem. 2022;10:974854. doi:10.3389/fchem.2022.974854
   PubMed Web of Science ®Google Scholar
• van Gool MMJ, van Egmond M. IgA and FcαRI: versatile players in homeostasis, infection, and autoimmunity. Immunotargets Ther. 2020;9:351–372. doi:10.2147/itt.S266242
   PubMed Web of Science ®Google Scholar
• Assad S, Khan HH, Ghazanfar H, et al. Role of sex hormone levels and psychological stress in the pathogenesis of autoimmune diseases. Cureus. 2017;9(6):e1315. doi:10.7759/cureus.1315
   PubMed Web of Science ®Google Scholar
• Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279. doi:10.3389/fimmu.2018.02279
   PubMed Web of Science ®Google Scholar
• Moxley G, Posthuma D, Carlson P, et al. Sexual dimorphism in innate immunity. Arthritis Rheum. 2002;46(1):250–258. doi:10.1002/1529-0131(200201)46:1<250::Aid-art10064>3.0.Co;2-t
   PubMedGoogle Scholar
• Hagman J. Critical functions of IRF4 in B and T lymphocytes. J Immunol. 2017;199(11):3715–3716. doi:10.4049/jimmunol.1701385
   PubMed Web of Science ®Google Scholar
• Panchanathan R, Shen H, Zhang X, Ho SM, Choubey D. Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PLoS One. 2010;5(5):e10868. doi:10.1371/journal.pone.0010868
   PubMed Web of Science ®Google Scholar
• Fan H, Zhao G, Ren D, Liu F, Dong G, Hou Y. Gender differences of B cell signature related to estrogen-induced IFI44L/BAFF in systemic lupus erythematosus. Immunol Lett. 2017;181:71–78. doi:10.1016/j.imlet.2016.12.002
   PubMed Web of Science ®Google Scholar
• Rubtsova K, Marrack P, Rubtsov AV. Sexual dimorphism in autoimmunity. J Clin Invest. 2015;125(6):2187–2193. doi:10.1172/jci78082
   PubMed Web of Science ®Google Scholar